Jeff P. Coon
Human Resources Officer bij DYNAVAX TECHNOLOGIES CORPORATION
Profiel
Jeff P.
Coon holds the position of Senior VP-Human Resources & Corporate Services at Dynavax Technologies Corp.
He previously occupied the position of Director-Human Resources at Johnson & Johnson, Vice President-Human Resources for Exelixis, Inc., Human Resources Director at Cobham Ltd., Director-Human Resources at PDL BioPharma, Inc., Vice President-Human Resources at Assertio Therapeutics, Inc., Senior Vice President-Human Resources for Five Prime Therapeutics, Inc. and Vice President-Human Resources of CD Holding, Inc.
He received a graduate degree from Golden Gate University and an undergraduate degree from The California State University.
Actieve functies van Jeff P. Coon
Bedrijven | Functie | Begin |
---|---|---|
DYNAVAX TECHNOLOGIES CORPORATION | Human Resources Officer | 01-01-2019 |
Eerdere bekende functies van Jeff P. Coon
Bedrijven | Functie | Einde |
---|---|---|
FIVE PRIME THERAPEUTICS, INC. | Human Resources Officer | 01-01-2019 |
Assertio Therapeutics, Inc.
Assertio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Assertio Therapeutics, Inc. engages in the manufacture and distribution of pharmaceutical products to treat pain and other central nervous system conditions. Its brands include Gralise, Zipsor, Lazanda, Cambia, NUCYNTA ER and NUCYNTA. The firm focuses on neurology, orphan and specialty medicines. The company was founded by John W. Shell on August 7, 1995 and is headquartered in Lake Forest, IL. | Chief Administrative Officer | 01-01-2017 |
COBHAM | Human Resources Officer | 01-08-2011 |
EXELIXIS, INC. | Human Resources Officer | 01-01-2009 |
PDL BIOPHARMA, INC. | Human Resources Officer | 01-01-2008 |
Opleiding van Jeff P. Coon
The California State University | Undergraduate Degree |
Golden Gate University | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 3 |
---|---|
JOHNSON & JOHNSON | Health Technology |
EXELIXIS, INC. | Health Technology |
DYNAVAX TECHNOLOGIES CORPORATION | Health Technology |
Bedrijven in privébezit | 5 |
---|---|
Assertio Therapeutics, Inc.
Assertio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Assertio Therapeutics, Inc. engages in the manufacture and distribution of pharmaceutical products to treat pain and other central nervous system conditions. Its brands include Gralise, Zipsor, Lazanda, Cambia, NUCYNTA ER and NUCYNTA. The firm focuses on neurology, orphan and specialty medicines. The company was founded by John W. Shell on August 7, 1995 and is headquartered in Lake Forest, IL. | Health Technology |
Five Prime Therapeutics, Inc.
Five Prime Therapeutics, Inc. BiotechnologyHealth Technology Five Prime Therapeutics, Inc. is a clinical-stage biotechnology company, which engages in the discovery and development of novel protein therapeutics. Its product candidates includes, Cabiralizumab (FPA008), Bemarituzumab (FPA144), and FPA150. The FPA008 is an antibody that inhibits colony stimulating factor-1, or CSF1, receptor, or CSF1R, that are developing in rheumatoid arthritis and plan to clinically develop in pigmented villonodular synovitis, or PVNS, and in combination with nivolumab in multiple cancers. The FPA144 is an antibody that inhibits fibroblast growth factor receptor 2b, or FGFR2b, that are developing to treat patients with gastric cancer. The FPA150 is a CD8 T cell checkpoint which targets B7-H4 that is developing as a monotherapy in multiple cancers. The company was founded by Lewis T. Williams in December 2001 and is headquartered in South San Francisco, C. | Health Technology |
Cobham Ltd.
Cobham Ltd. Information Technology ServicesTechnology Services Cobham Ltd. designs and manufactures civil and military aerospace equipment and specialized systems and components. The firm offers refuelling equipment, aviation oxygen systems, weapon system containers, and rescue and navigation lights. The company was founded by Alan John Cobham on October 29, 1934 and is headquartered in Wimborne, the United Kingdom. | Technology Services |
PDL BioPharma, Inc.
PDL BioPharma, Inc. BiotechnologyHealth Technology PDL BioPharma, Inc. engages in the business of developing innovative therapeutics and healthcare technologies. It operates under the Medical Devices and Income Generating Assets segments. The Medical Devices segment focuses on the sale and lease of the LENSAR laser system which includes equipment, patient interface devices, procedure licenses, training, installation, warranty, and maintenance agreements. The Income Generating Assets segment offers notes and other long-term receivables; royalty rights, hybrid notes, and royalty receivables; equity investments; and royalties from issued patents covering the humanization of antibodies. The company was founded by Cary L. Queen and Laurence Jay Korn in 1986 and is headquartered in Reno, NV. | Health Technology |
CD Holding, Inc. | Consumer Services |